Stefan Schwartz
Overview
Explore the profile of Stefan Schwartz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
154
Citations
3408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heldrup J, Bleyer A, Ramsey L, Schaff L, Bernhardt B, Schwartz S, et al.
Cancer Chemother Pharmacol
. 2025 Mar;
95(1):41.
PMID: 40075030
Purpose: Folinic acid (FA) rescue protocols to counter the adverse effects of high-dose methotrexate (HDMTX) vary widely, and the risk of over-rescue and potential adverse effects of excessive FA (e.g.,...
2.
Nothnagel A, Schwartz S, Abramovich I, Schneider T, Angermair S, Treskatsch S
Front Cardiovasc Med
. 2024 Dec;
11:1476962.
PMID: 39660118
Heat exposure could cause organ injuries leading to multi-organ failure. This case report describes a cardiopulmonary healthy 61-year-old woman who was admitted to our university hospital in an unconscious state...
3.
Bielack S, Soussain C, Fox C, Houillier C, Murciano T, Osborne W, et al.
J Cancer Res Clin Oncol
. 2024 Oct;
150(10):441.
PMID: 39356310
High-dose methotrexate (HDMTX) is used in the treatment of a range of adult and childhood cancers. Although HDMTX can provide effective anti-tumor activity with an acceptable safety profile for most...
4.
Jonsson J, Zhai Q, Schwartz S, Kajitani N
J Virol
. 2024 Sep;
98(10):e0095124.
PMID: 39287390
The mRNAs encoding the human papillomavirus type 16 (HPV16) E6 and E7 oncogene mRNAs are subjected to extensive alternative RNA splicing at multiple regulated splice sites. One of the most...
5.
Knornschild F, Liebig S, Kiessling P, Prpic M, Kim T, Keller U, et al.
Clin Chem Lab Med
. 2024 Jul;
63(1):e11-e15.
PMID: 38997789
No abstract available.
6.
Neumann M, Beder T, Bastian L, Hanzelmann S, Bultmann M, Wolgast N, et al.
Leukemia
. 2024 May;
38(6):1213-1222.
PMID: 38744920
In contrast to B-cell precursor acute lymphoblastic leukemia (ALL), molecular subgroups are less well defined in T-lineage ALL. Comprehensive studies on molecular T-ALL subgroups have been predominantly performed in pediatric...
7.
Tolle M, Gokbuget N, Habringer S, Keller U, Schwartz S
Ann Hematol
. 2024 May;
103(8):3269-3271.
PMID: 38733396
No abstract available.
8.
Burmeister T, Stroh A, Kehden B, Trautmann H, Meyer C, Marschalek R, et al.
Leukemia
. 2024 Mar;
38(7):1600-1603.
PMID: 38519799
No abstract available.
9.
Schwartz S, Wu C, Kajitani N
J Med Virol
. 2024 Feb;
96(2):e29473.
PMID: 38362929
Human papillomaviruses (HPVs) cause more than 4.5% of all cancer in the world and more than half of these cases are attributed to human papillomavirus type 16 (HPV16). Prophylactic vaccines...
10.
Lohm G, Knornschild F, Neumann K, Budach V, Schwartz S, Burock S, et al.
Cancers (Basel)
. 2024 Feb;
16(3).
PMID: 38339285
In patients with prostate cancer (PCa), salvage radiotherapy (SRT) for biochemical progression (BP) after radical prostatectomy (RP) improves PCa-specific survival. However, no prospective randomized trials have compared the effect of...